Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azacitidine in elderly AML
NCT00728520Phase 2Unknown
- Sponsor
- Kansas City VA Medical Center
- Start
- Jul 2008
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of azacitidine in acute myeloid leukemia (AML), sponsored by Kansas City VA Medical Center. Status: unknown.
02
Drugs
azacitidine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00728520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00728520.